194 related articles for article (PubMed ID: 32062624)
1. Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.
Tachibana K; Matsuura K; Shindo A; Matsuyama H; Ii Y; Taniguchi A; Tomimoto H
Intern Med; 2020; 59(4):485-490. PubMed ID: 32062624
[TBL] [Abstract][Full Text] [Related]
2. Combined use of dopamine transporter imaging (DAT-SPECT) and
Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
[TBL] [Abstract][Full Text] [Related]
3. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
[TBL] [Abstract][Full Text] [Related]
4. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
Lorberboym M; Treves TA; Melamed E; Lampl Y; Hellmann M; Djaldetti R
Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
[TBL] [Abstract][Full Text] [Related]
5. The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.
Sixel-Döring F; Liepe K; Mollenhauer B; Trautmann E; Trenkwalder C
J Neurol; 2011 Dec; 258(12):2147-54. PubMed ID: 21547379
[TBL] [Abstract][Full Text] [Related]
6. Combined use of ¹²³I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study.
Kim JS; Oh YS; Kim YI; Yang DW; Chung YA; You IeR; Lee KS
Arch Gerontol Geriatr; 2013; 56(1):124-8. PubMed ID: 22633343
[TBL] [Abstract][Full Text] [Related]
7. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
[TBL] [Abstract][Full Text] [Related]
8. DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.
Yomtoob J; Koloms K; Bega D
Parkinsonism Relat Disord; 2018 Aug; 53():37-41. PubMed ID: 29748111
[TBL] [Abstract][Full Text] [Related]
9. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
[TBL] [Abstract][Full Text] [Related]
10. [[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study].
Yamada A; Murakami T; Kang Y; Iikuni Y; Morimatsu A; Shirata A; Ito H; Ugawa Y; Yamane K
Rinsho Shinkeigaku; 2016 Jun; 56(6):400-6. PubMed ID: 27212677
[TBL] [Abstract][Full Text] [Related]
11.
Yoshii F; Moriya Y; Ohnuki T; Ryo M; Takahashi W; Kohara S; Hashimoto J
Clin Neurol Neurosurg; 2017 Sep; 160():73-77. PubMed ID: 28689103
[TBL] [Abstract][Full Text] [Related]
12. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease.
Diaz-Corrales FJ; Sanz-Viedma S; Garcia-Solis D; Escobar-Delgado T; Mir P
Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):556-64. PubMed ID: 19862520
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of combining
Niimi Y; Ito S; Murate K; Hirota S; Hikichi C; Ishikawa T; Maeda T; Nagao R; Shima S; Mizutani Y; Ueda A; Mutoh T
J Neurol Sci; 2017 Jun; 377():174-178. PubMed ID: 28477690
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease.
Benítez-Rivero S; Marín-Oyaga VA; García-Solís D; Huertas-Fernández I; García-Gómez FJ; Jesús S; Cáceres MT; Carrillo F; Ortiz AM; Carballo M; Mir P
J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):122-9. PubMed ID: 22906618
[TBL] [Abstract][Full Text] [Related]
16. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
Navarro-Otano J; Gaig C; Muxi A; Lomeña F; Compta Y; Buongiorno MT; Martí MJ; Tolosa E; Valldeoriola F
Parkinsonism Relat Disord; 2014 Feb; 20(2):192-7. PubMed ID: 24252299
[TBL] [Abstract][Full Text] [Related]
17. DAT SPECT may have diagnostic value in prodromal SCA2 patients with parkinsonism.
Miyaue N; Tada S; Ando R; Iwaki H; Yabe H; Nishikawa N; Nagai M; Takashima H; Nomoto M
Parkinsonism Relat Disord; 2017 Nov; 44():137-141. PubMed ID: 28844804
[TBL] [Abstract][Full Text] [Related]
18. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
[TBL] [Abstract][Full Text] [Related]
20. Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors.
Novellino F; Arabia G; Bagnato A; Cascini GL; Salsone M; Nicoletti G; Messina D; Morelli M; Paglionico S; Giofrè L; Restuccia A; Torchia G; Condino F; Quattrone A
Mov Disord; 2009 Nov; 24(15):2242-8. PubMed ID: 19795467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]